drugset / Trial / NCT00901628
Periarticular Multimodal Drug Injections in Total Knee Arthroplasty
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether periarticular multimodal drug injection (PMDI) would provide additional benefits in patients after total knee arthroplasty (TKA) for whom contemporary pain control protocols using the continuous femoral nerve block, intra-venous patient controlled analgesia (IV-PCA)and preemptive oral medications. We hypothesized that PMDI would reduce pain level and consumption of PCA and acute pain rescuer and would provide better functional recovery and patient satisfaction. We also hypothesized that the incidence of side effects and complications of the PMDI would be similar to the No-PMDI.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-03
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cefuroxime | Small molecule | 750 mg | Other |
| Subject | Epinephrine | Other / unclassified | 300 ug | Other |
| Subject | Ketorolac | Other / unclassified | 30 mg | Other |
| Subject | Morphine | Other / unclassified | 10 mg | Other |
| Subject | Ropivacaine | Other / unclassified | 300 mg | Other |